Skip to main content

Advertisement

Log in

The emergence and dissemination of CTX-M-producing Escherichia coli sequence type 131 causing community-onset bacteremia in Israel

  • Article
  • Published:
European Journal of Clinical Microbiology & Infectious Diseases Aims and scope Submit manuscript

Abstract

Community-onset bloodstream infections caused by extended-spectrum β-lactamase-producing Escherichia coli (ESBL-EC-COBSIs) were investigated over a 7-year-period (2003–2009) in our institution. ESBL-EC-COBSI inclusion criteria were cefotaxime/ceftazidime non-susceptible blood isolates recovered during 48 h upon hospital admission. Forty-one isolates were molecularly characterized. Susceptibilities were determined (Vitek-2) and genotyping was performed [multilocus sequence typing (MLST)]. CTX-M genes were determined [polymerase chain reaction (PCR) and sequencing] and bla CTX-M-encoding plasmids (n = 10) were analyzed and compared. Phylogrouping and virulence genes were identified (PCR). The incidence rate of ESBL-EC-COBSIs has increased from 2.94 to 7.87 cases/10,000 admissions. All isolates were multidrug-resistant (MDR), displaying co-resistance to ciprofloxacin (93 %), trimethoprim–sulfamethoxazole (85 %), and gentamicin (51 %). MLST identified ten sequence types (STs), of which five were novel. ST131 accounted for 66 % of the cases (27/41), and dominated over the years (prevalence of 25 % in 2003 and 85 % in 2009). All isolates carried CTX-M genes with the following prevalence: bla CTX-M-2 (6/8; 75 %) in 2003; bla CTX-M-15 (9/13, 69 % in 2007); and bla CTX-M-15 (11/20, 55 %) and bla CTX-M-14 (7/20, 35 %) in 2009. bla CTX-M-15- and bla CTX-M-14-encoding plasmids harbored by ST131 differed. Of all isolates, 98 % belonged to virulent phylogroups B2 (28/41, 68 %) and D (12/41, 29 %), though ST131 isolates carried a higher number of virulence genes compared to other lineages (p < 0.05). The incidence of ESBL-EC-COBSIs increased 2.7-fold during the period 2003–2009. This increase appears to be related to the emergence and clonal expansion of bla CTX-M-15- or bla CTX-M-14-carrying ST131. The superiority of this virulent lineage should be further explored.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Rodriguez-Bano J, Navarro MD, Romero L, Muniain MA, de Cueto M, Rios MJ, Hernandez JR, Pascual A (2006) Bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coli in the CTX-M era: a new clinical challenge. Clin Infect Dis 43(11):1407–1414

    Article  PubMed  Google Scholar 

  2. Paterson DL, Bonomo RA (2005) Extended-spectrum beta-lactamases: a clinical update. Clin Microbiol Rev 18(4):657–686

    Article  PubMed  CAS  Google Scholar 

  3. Pitout JD, Nordmann P, Laupland KB, Poirel L (2005) Emergence of Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs) in the community. J Antimicrob Chemother 56(1):52–59

    Article  PubMed  CAS  Google Scholar 

  4. Rogers BA, Sidjabat HE, Paterson DL (2011) Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain. J Antimicrob Chemother 66(1):1–14

    Article  PubMed  CAS  Google Scholar 

  5. Cantón R, Coque TM (2006) The CTX-M beta-lactamase pandemic. Curr Opin Microbiol 9(5):466–475

    Article  PubMed  Google Scholar 

  6. Oteo J, Lázaro E, de Abajo FJ, Baquero F, Campos J; Spanish members of EARSS (2005) Antimicrobial-resistant invasive Escherichia coli, Spain. Emerg Infect Dis 11(4):546–553

    Article  PubMed  CAS  Google Scholar 

  7. Nicolas-Chanoine MH, Blanco J, Leflon-Guibout V, Demarty R, Alonso MP, Caniça MM, Park YJ, Lavigne JP, Pitout J, Johnson JR (2008) Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. J Antimicrob Chemother 61(2):273–281

    Article  PubMed  CAS  Google Scholar 

  8. Blanco M, Alonso MP, Nicolas-Chanoine MH, Dahbi G, Mora A, Blanco JE, López C, Cortés P, Llagostera M, Leflon-Guibout V, Puentes B, Mamani R, Herrera A, Coira MA, García-Garrote F, Pita JM, Blanco J (2009) Molecular epidemiology of Escherichia coli producing extended-spectrum {beta}-lactamases in Lugo (Spain): dissemination of clone O25b:H4-ST131 producing CTX-M-15. J Antimicrob Chemother 63(6):1135–1141

    Article  PubMed  CAS  Google Scholar 

  9. Colodner R, Samra Z, Keller N, Sprecher H, Block C, Peled N, Lazarovitch T, Bardenstein R, Schwartz-Harari O, Carmeli Y; Israel ESBL Group (2007) First national surveillance of susceptibility of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. to antimicrobials in Israel. Diagn Microbiol Infect Dis 57(2):201–205

    Article  PubMed  CAS  Google Scholar 

  10. Navon-Venezia S, Chmelnitsky I, Leavitt A, Carmeli Y (2008) Dissemination of the CTX-M-25 family beta-lactamases among Klebsiella pneumoniae, Escherichia coli and Enterobacter cloacae and identification of the novel enzyme CTX-M-41 in Proteus mirabilis in Israel. J Antimicrob Chemother 62(2):289–295

    Article  PubMed  CAS  Google Scholar 

  11. Chmelnitsky I, Carmeli Y, Leavitt A, Schwaber MJ, Navon-Venezia S (2005) CTX-M-2 and a new CTX-M-39 enzyme are the major extended-spectrum beta-lactamases in multiple Escherichia coli clones isolated in Tel Aviv, Israel. Antimicrob Agents Chemother 49(11):4745–4750

    Article  PubMed  CAS  Google Scholar 

  12. Ben-Ami R, Schwaber MJ, Navon-Venezia S, Schwartz D, Giladi M, Chmelnitsky I, Leavitt A, Carmeli Y (2006) Influx of extended-spectrum beta-lactamase-producing enterobacteriaceae into the hospital. Clin Infect Dis 42(7):925–934

    Article  PubMed  CAS  Google Scholar 

  13. Clinical and Laboratory Standards Institute (CLSI) (2008) Performance standards for antimicrobial susceptibility testing; eighteenth informational supplement. CLSI document MS100-S18. CLSI, Wayne, PA

  14. Carter MW, Oakton KJ, Warner M, Livermore DM (2000) Detection of extended-spectrum beta-lactamases in Klebsiellae with the Oxoid combination disk method. J Clin Microbiol 38(11):4228–4232

    PubMed  CAS  Google Scholar 

  15. Vila J, Marcos MA, Jimenez de Anta MT (1996) A comparative study of different PCR-based DNA fingerprinting techniques for typing of the Acinetobacter calcoaceticusA. baumannii complex. J Med Microbiol 44(6):482–489

    Article  PubMed  CAS  Google Scholar 

  16. Woodford N, Fagan EJ, Ellington MJ (2006) Multiplex PCR for rapid detection of genes encoding CTX-M extended-spectrum (beta)-lactamases. J Antimicrob Chemother 57(1):154–155

    Article  PubMed  CAS  Google Scholar 

  17. Poirel L, Decousser JW, Nordmann P (2003) Insertion sequence ISEcp1B is involved in expression and mobilization of a bla(CTX-M) beta-lactamase gene. Antimicrob Agents Chemother 47(9):2938–2945

    Article  PubMed  CAS  Google Scholar 

  18. Clermont O, Bonacorsi S, Bingen E (2000) Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Microbiol 66(10):4555–4558

    Article  PubMed  CAS  Google Scholar 

  19. Bingen-Bidois M, Clermont O, Bonacorsi S, Terki M, Brahimi N, Loukil C, Barraud D, Bingen E (2002) Phylogenetic analysis and prevalence of urosepsis strains of Escherichia coli bearing pathogenicity island-like domains. Infect Immun 70(6):3216–3226

    Article  PubMed  CAS  Google Scholar 

  20. Drieux L, Brossier F, Duquesnoy O, Aubry A, Robert J, Sougakoff W, Lecso-Bornet M, Jarlier V (2009) Increase in hospital-acquired bloodstream infections caused by extended spectrum beta-lactamase-producing Escherichia coli in a large French teaching hospital. Eur J Clin Microbiol Infect Dis 28(5):491–498

    Article  PubMed  CAS  Google Scholar 

  21. Melzer M, Petersen I (2007) Mortality following bacteraemic infection caused by extended spectrum beta-lactamase (ESBL) producing E. coli compared to non-ESBL producing E. coli. J Infect 55(3):254–259

    Article  PubMed  Google Scholar 

  22. Pitout JD, Gregson DB, Campbell L, Laupland KB (2009) Molecular characteristics of extended-spectrum-beta-lactamase-producing Escherichia coli isolates causing bacteremia in the Calgary Health Region from 2000 to 2007: emergence of clone ST131 as a cause of community-acquired infections. Antimicrob Agents Chemother 53(7):2846–2851

    Article  PubMed  CAS  Google Scholar 

  23. Rossolini GM, D’Andrea MM, Mugnaioli C (2008) The spread of CTX-M-type extended-spectrum beta-lactamases. Clin Microbiol Infect 14(Suppl 1):33–41

    Article  PubMed  CAS  Google Scholar 

  24. Clermont O, Lavollay M, Vimont S, Deschamps C, Forestier C, Branger C, Denamur E, Arlet G (2008) The CTX-M-15-producing Escherichia coli diffusing clone belongs to a highly virulent B2 phylogenetic subgroup. J Antimicrob Chemother 61(5):1024–1028

    Article  PubMed  CAS  Google Scholar 

  25. Coelho A, Mora A, Mamani R, López C, González-López JJ, Larrosa MN, Quintero-Zarate JN, Dahbi G, Herrera A, Blanco JE, Blanco M, Alonso MP, Prats G, Blanco J (2011) Spread of Escherichia coli O25b:H4-B2-ST131 producing CTX-M-15 and SHV-12 with high virulence gene content in Barcelona (Spain). J Antimicrob Chemother 66(3):517–526

    Article  PubMed  CAS  Google Scholar 

  26. Johnson JR, Russo TA (2002) Extraintestinal pathogenic Escherichia coli: “the other bad E coli”. J Lab Clin Med 139(3):155–162

    Article  PubMed  CAS  Google Scholar 

  27. Jauréguy F, Carbonnelle E, Bonacorsi S, Clec’h C, Casassus P, Bingen E, Picard B, Nassif X, Lortholary O (2007) Host and bacterial determinants of initial severity and outcome of Escherichia coli sepsis. Clin Microbiol Infect 13(9):854–862

    Article  PubMed  Google Scholar 

  28. Karisik E, Ellington MJ, Livermore DM, Woodford N (2008) Virulence factors in Escherichia coli with CTX-M-15 and other extended-spectrum beta-lactamases in the UK. J Antimicrob Chemother 61(1):54–58

    Article  PubMed  CAS  Google Scholar 

  29. de Lorenzo V, Martinez JL (1988) Aerobactin production as a virulence factor: a reevaluation. Eur J Clin Microbiol Infect Dis 7(5):621–629

    Article  PubMed  Google Scholar 

  30. Montgomerie JZ, Bindereif A, Neilands JB, Kalmanson GM, Guze LB (1984) Association of hydroxamate siderophore (aerobactin) with Escherichia coli isolated from patients with bacteremia. Infect Immun 46(3):835–838

    PubMed  CAS  Google Scholar 

  31. Peirano G, Pitout JD (2010) Molecular epidemiology of Escherichia coli producing CTX-M beta-lactamases: the worldwide emergence of clone ST131 O25:H4. Int J Antimicrob Agents 35(4):316–321

    Article  PubMed  CAS  Google Scholar 

  32. Woodford N, Carattoli A, Karisik E, Underwood A, Ellington MJ, Livermore DM (2009) Complete nucleotide sequences of plasmids pEK204, pEK499, and pEK516, encoding CTX-M enzymes in three major Escherichia coli lineages from the United Kingdom, all belonging to the international O25:H4-ST131 clone. Antimicrob Agents Chemother 53(10):4472–4482

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

We would like to thank the platform Genotyping of Pathogens and Public Health (Institut Pasteur) for the coding of all novel MLST alleles and profiles.

This work was performed in partial fulfillment of the requirements for an M.Sc. degree of Daphne Karfunkel, Sackler Faculty of Medicine, Tel Aviv University, Israel.

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to S. Navon-Venezia.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Karfunkel, D., Carmeli, Y., Chmelnitsky, I. et al. The emergence and dissemination of CTX-M-producing Escherichia coli sequence type 131 causing community-onset bacteremia in Israel. Eur J Clin Microbiol Infect Dis 32, 513–521 (2013). https://doi.org/10.1007/s10096-012-1765-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10096-012-1765-9

Keywords

Navigation